Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Health-care companies ticked up, but lost ground during a generally positive week for the stock market amid fears about the implications of a tight presidential race for health-care regulation.

The Mobile Police Department arrested 26 people Wednesday and Thursday as a three-month investigation targeting the city's ...

Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...

Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

Queen Silvia of Sweden and U.S. Ambassador to Sweden attended in support of Alzheimer's Drug Discovery Foundation's mission ...

DNA might contain health information, but unlike a doctor’s office, 23andMe is not bound by the health-privacy law HIPAA. And ...

The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. The medication, formerly known as KarXT, is the first antipsychotic medication to ...

In a breakthrough for people with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication, which will be marketed under the name ...

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

CONWAY, S.C. (WMBF) – One man’s trial ended sooner than planned. The 15th Circuit Solicitor’s Office announced on Friday that 37-year-old Napoleon Richardson Jr. pleaded guilty to several charges and ...